HeartWare International, Inc.·4

Mar 12, 5:24 PM ET

HeartWare International, Inc. 4

4 · HeartWare International, Inc. · Filed Mar 12, 2014

Insider Transaction Report

Form 4
Period: 2014-03-10
Hathaway David R
Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2014-03-10$95.00/sh1,601$152,0950 total
  • Sale

    Common Stock

    2014-03-11$95.00/sh2,812$267,1400 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2014-03-112,8120 total
    Exercise: $18.02From: 2012-08-13Exp: 2018-08-13Common Stock (2,812 underlying)
  • Exercise/Conversion

    Common Stock

    2014-03-10$18.08/sh+299$5,4061,601 total
  • Exercise/Conversion

    Common Stock

    2014-03-11$18.02/sh+2,812$50,6722,812 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2014-03-102992,812 total
    Exercise: $18.08From: 2012-08-13Exp: 2018-08-13Common Stock (299 underlying)
Footnotes (4)
  • [F1]The purchase price of US$18.08 has been converted from AU$19.95 at the spot rate on the date of the transaction.
  • [F2]The purchase price of US$18.02 has been converted from AU$19.95 at the spot rate on the date of the transaction.
  • [F3]The exercise price of US$18.08 has been converted from AU$19.95 at the spot rate on the date of the transaction.
  • [F4]The exercise price of US$18.02 has been converted from AU$19.95 at the spot rate on the date of the transaction.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION